Acute lipopolysaccharide (LPS)-induced cell membrane hyperpolarization is independent of voltage gated and calcium activated potassium channels

Comp Biochem Physiol C Toxicol Pharmacol. 2024 Nov:285:110004. doi: 10.1016/j.cbpc.2024.110004. Epub 2024 Aug 16.

Abstract

The gram-negative toxin lipopolysaccharides (LPS) are known to trigger inflammatory cytokines in mammals, which can result in pathological responses. Upon treatment of bacterial sepsis with antibiotics, the lysing bacteria can present a surge in LPS, inducing a cytokine storm. However, LPS can also have direct cellular effects, including transient rapid hyperpolarizing of the membrane potential, blocking glutamate receptors and even promoting release of glutamate. The detailed mechanism of action for these immediate responses is still unresolved. In addressing the membrane hyperpolarization, voltage gated K+ channel blockers 4-aminopyridine (4-AP, 3 mM), quinidine hydrochloride monohydrate (0.1 mM) and tetraethylammonium (TEA, 20 mM) were examined along with RNAi knockdowns of potential calcium activated K+ channels. The immediate responses of LPS were not blocked. Even in the presence of glutamate, the membrane still hyperpolarizes with LPS. When the driving gradient for the ionotropic glutamate receptors is enhanced during hyperpolarization, spontaneous quantal responses are dampened in amplitude. Thus, glutamate receptors are blocked, and the mechanism of hyperpolarization remains unresolved. The larval Drosophila glutamatergic neuromuscular junction is used as a model synaptic preparation to address the direct rapid actions by LPS.

Keywords: Drosophila; Lipopolysaccharides; Membrane potential; Pharmacology; Potassium channel.

MeSH terms

  • Animals
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Drosophila melanogaster
  • Glutamic Acid / metabolism
  • Glutamic Acid / pharmacology
  • Larva / drug effects
  • Larva / metabolism
  • Lipopolysaccharides* / pharmacology
  • Membrane Potentials* / drug effects
  • Neuromuscular Junction / drug effects
  • Neuromuscular Junction / metabolism
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Calcium-Activated / metabolism
  • Potassium Channels, Voltage-Gated / metabolism

Substances

  • Lipopolysaccharides
  • Potassium Channels, Calcium-Activated
  • Potassium Channels, Voltage-Gated
  • Glutamic Acid
  • Potassium Channel Blockers